Pneumonia
📧 Sign up to get email alerts when something new happens for Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-10Clinical Trial Update: mHealth for Pneumonia Prevention [NA]
Completed clinical study evaluating mobile health tools to prevent pneumonia in children, sponsored by the University of Edinburgh. The prov…
-
CLINICAL_TRIALS research · 2024-06-10Clinical Trial Update: Pneumonia Policy Formation in Pakistan
A completed clinical trial led by the University of Edinburgh studying pneumonia policy formation in Pakistan.
-
CLINICAL_TRIALS trial_result · 2024-05-23Clinical Trial Update: SP16 as a Therapeutic for COVID-19 Induced ARDS [Phase 1]
Phase 1 trial of SP16 for COVID-19-induced acute respiratory distress syndrome has been terminated by Serpin Pharma, LLC.
-
CLINICAL_TRIALS research · 2024-05-23Clinical Trial Update: Emergency PWAS in Respiratory Infectious Disease
A University of Hong Kong-led clinical trial on emergency PWAS for respiratory infectious disease is currently recruiting, focusing on pneum…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Impact of Physical Therapy of Dysphagia on Preventing Pneumonia in Acute Stroke Patients [NA]
This completed clinical trial evaluated whether physical therapy for dysphagia could prevent pneumonia in patients with acute stroke.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-05-01FDA Approved: PIPERACILLIN AND TAZOBACTAM — Supplemental Application (Civica, Inc.)
FDA approved a supplemental application for Civica, Inc. for Piperacillin and Tazobactam (piperacillin/tazobactam).
-
FDA approval · 2024-05-01FDA Approved: PIPERACILLIN AND TAZOBACTAM — Supplemental Application (Eugia US LLC)
FDA approved a supplemental ANDA for Piperacillin and Tazobactam (piperacillin sodium and tazobactam sodium) manufactured by Eugia US LLC.
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6) [Phase 3]
A Phase 3 trial (STRIDE-6) evaluating the safety, tolerability, and immunogenicity of the V116 pneumococcal vaccine in adults with prior pne…
-
CLINICAL_TRIALS withdrawal · 2024-04-26Clinical Trial Update: Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19) [Phase 2]
A Phase 2 trial evaluating jaktinib for severe COVID-19 pneumonia has been withdrawn.
-
FDA approval · 2024-04-25FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (NorthStar Rx LLC)
FDA approved a Supplemental Application for Amoxicillin and clavulanate potassium by NorthStar Rx LLC, indicating a modification to an exist…
-
FDA approval · 2024-04-25FDA Approved: AMOXICILLIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for amoxicillin submitted by Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure [NA]
A completed trial evaluated text message nudges delivered before primary care visits to improve closing of care gaps. The study status is co…
-
FDA approval · 2024-04-24FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Amoxicillin and Clavulanate Potassium from Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: The Effect of Zoledronate on the Prevention of Pneumonia in Hip Fracture Patients [Phase 4]
Phase 4 trial exploring whether zoledronate can prevent pneumonia in patients with hip fractures.
-
CLINICAL_TRIALS trial_result · 2024-02-15Clinical Trial Update: Procalcitonin to Reduce Antibiotic Use in Pediatric Pneumonia [EARLY_Phase 1]
Early-phase trial evaluating procalcitonin to guide antibiotic use in pediatric pneumonia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months，7 Months-5 Years [Phase 4]
A Phase 4 study evaluating the persistence of immunity of PCV13 in healthy children aged 2 months to 5 years, completed.
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients [Phase 4]
Phase 4 trial updates the efficacy of intravenous Amboxol hydrochloride as an adjunct therapy for severe pneumonia in critically ill patient…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: BL Infusion Trial:Beta-lactam Continuous Versus Intermittent Infusion and Associated Bacterial Resistance and Therapy Outcomes in Critically Ill Patients With Severe Pneumonia [Phase 4]
Phase 4 trial comparing beta-lactam continuous versus intermittent infusion in critically ill pneumonia patients; study terminated with post…
-
CLINICAL_TRIALS trial_result · 2023-12-04Clinical Trial Update: Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children [Phase 4]
Phase 4 clinical trial evaluating azithromycin to prevent post-discharge morbidity and mortality in Kenyan children.
-
CLINICAL_TRIALS trial_result · 2023-11-27Clinical Trial Update: Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia [Phase 3]
A Phase 3 trial comparing intravenous N-acetylcysteine plus oseltamivir versus oseltamivir alone in adults hospitalized with influenza and p…
-
FDA approval · 2023-11-21FDA Approved: LINEZOLID — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for Linezolid (generic linezolid) under ANDA 211813. This action confirms appr…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: A Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19) [Phase 2]
Phase 2 clinical trial update for ADR-001 in patients with severe pneumonia due to SARS-CoV-2 (COVID-19) has completed.
-
FDA approval · 2023-10-12FDA Approved: PIPERACILLIN AND TAZOBACTAM — Original Application (Eugia US LLC)
FDA approved the original abbreviated new drug application for piperacillin and tazobactam, a combination antibiotic manufactured by Eugia U…
-
CLINICAL_TRIALS research · 2023-10-03Clinical Trial Update: A COHORT STUDY TO EVALUATE IMMUNOGENICITY FOR CHINESE CHILDREN AT THE TIME OF CLINICAL PNEUMONIA DIAGNOSIS [NA]
A completed clinical trial evaluating immunogenicity of a vaccine in Chinese children at the time of clinical pneumonia diagnosis.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Extracellular Vesicles From Mesenchymal Cells in the Treatment of Acute Respiratory Failure [Phase 1, Phase 2]
A phase 1/2 clinical trial is investigating extracellular vesicles derived from mesenchymal cells for treating acute respiratory failure, in…